Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | — | — | — | 1 |
Fallopian tube neoplasms | D005185 | — | — | — | 1 | — | — | — | 1 |
Ovarian epithelial carcinoma | D000077216 | — | — | — | 1 | — | — | — | 1 |
Drug common name | PLEVITREXED |
INN | plevitrexed |
Description | Plevitrexed is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target thymidylate synthase. |
Classification | Small molecule |
Drug class | antineoplastic thymidylate synthetase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C#CCN(Cc1cc2c(O)nc(C)nc2cc1C)c1ccc(C(=O)N[C@@H](CCc2nnn[nH]2)C(=O)O)c(F)c1 |
PDB | — |
CAS-ID | 153537-73-6 |
RxCUI | — |
ChEMBL ID | CHEMBL126648 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | L9P2881C3H (ChemIDplus, GSRS) |